RTP 180 | Chemistry: Sara Wu
07/24/2019 | 6m 26s
Sara Wu from G1 Therapeutics talks about the Trilaciclib drug in development. She explains how the drug is made and what the diseases it would be used for. She addresses the RTP 180 event at The Frontier in Research Triangle Park, NC.
Problems Playing Video? | Closed Captioning